Navigation Links
Myeloperoxidase IgG ELISA

ProductsMyeloperoxidase IgG ELISA
Company Zeus Scientific, Inc.
Item Myeloperoxidase IgG ELISA
Features 
Description The Zeus Scientific, Inc. Myeloperoxidase IgG ELISA test system is intended for the qualitative and semi-quantitative detection of IgG-class antibody to myeloperoxidase in human serum. The test system is intended to be used as an aid in the diagnosis of various autoimmune vasculitic disorders characterized by elevated levels of anti-neutrophil cytoplasmic antibodies (ANCA). MPO-ANCA may be associated with autoimmune disorders such as Wegeners's granulamotosis, ICGN, MPA and PRS. This test is for in vitro diagnostic use.
Info Zeus Scientific, Inc.
Customer Service: (800) 286-2111
Web site: http://www.zeussci.com

Related medicine products :

1. Anti-MPO ANCA EIA Auto-Immune Markers 013-MPO-96 Myeloperoxidase
2. Anti-MPO ANCA EIA Auto-Immune Markers 013-MPO-48 Myeloperoxidase
3. Myeloperoxidase (MPO) Enzyme-Linked Immunosorbent Assay (ELISA)
4. Autostat II Anti-Myeloperoxidase ELISA
5. Anti-Myeloperoxidase-ANCA
6. ImmuLisa Anti-Myeloperoxidase MPO (pANCA)
7. Myeloperoxidase (MPO) II
8. Myeloperoxidase Stain
9. Myeloperoxidase Antibody
10. Microplate ELISA Washers - Manual Microplate Washer
11. Microplate ELISA Washers - Automated Microplate Washer
Improve your refractive outcome, with AXIS II precision biometry A-scan. Biometry clinically proven as accurate as partial coherence interferometry while not limited by dense media.
...ith graphic display and IOL power calculation soft...n units include firmware module with SRKII, SRKT, ...ble tones increase in frequency the closer you get...chieved with corneal indentation. Triple tone when...
...an exceptionally high resolution, versatile A/B-sc...eflection) display. This provides substantially mo...rs. Vitreous structures such as posterior hyaloid,...ascularity and macular edema are routinely detecte...
... system which quickly identifies ocular asymmetry....er by more than 0.3 mm, a staphyloma or other ocul...s quick and easy identification of suspected patho...ng shells under the lids. The B5500 B-scan provide...
Medicine Products:
(Date:8/8/2008)...gnosis, less successful surgery, pair of studies f... -- The standard screening test for prostate cance...more vulnerable to the disease, and surgery is les...tudies found. , "Obese men are more likely to b...," said Dr. Stephen Freedland, an associate profes...
(Date:8/8/2008)...A, Md., Aug. 8 /PRNewswire-FirstCall/ -- Hanger Or...nnounce that Moody,s Investors,Service revised its...itive",from "stable." Moody,s also affirmed Hanger...re pleased with the outlook change from Moody,s as...ten quarters," remarked George McHenry,Hanger,s C...
(Date:8/7/2008)...ls of testosterone may be a key factor in spreadin... findings could help explain why males in a popula...ansmit disease., , Previous research has linked...tem suppression. Studies have shown that males, co...e, and account for a larger share of disease trans...
(Date:8/7/2008)...urgh Tissue Engineering Initiative Marks 12th Year...p, PITTSBURGH, Aug. 7 /PRNewswire/ -- Twenty-four...ties, primarily across southwestern Pennsylvania,a...2th annual Summer,Internship Program of the Pittsb...l of the program is to expose greatly increased nu...
Breaking Medicine News(10 mins):Health News:Obese Men Face Twin Threat From Prostate Cancer 2Health News:Testosterone key to disease transmission 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 3
...nticipation of a fearful situation can play an imp... the University of Wisconsin-Madison, while conduc...f memory have come up with the findings that the v...l situation can stir up two memory-forming regions...
...atients taking newer blood pressure drugs have a d... an analysis of the biggest clinical trial in Euro...eople on newer medicines developed diabetes as aga...ugs. The study involved 19,000 people. The study ...
... study in the September issue of Archives of Pedia...ves journals says that hospitals must be prepared ...f and equipment to treat injured and noninjured ch...he report is based on the experience of training a...
...olgate-Palmolive (India) Limited, the market leade...tal Association (IDA) today announced that Septemb... in its third year, Oral Health Month (OHM) is an ...gn in India to establish and promote the importanc...
Other Medicine News:Health News:Anticipation Could Have An Intense Effect On Memory 2Health News:Anticipation Could Have An Intense Effect On Memory 3Health News:Military Hospitals Need To Be Prepared To Treat Children 2Health News:Striving to Make India Free from Tooth Decay 2
(Date:8/7/2008)...ve Decision to Expand its Proprietary ...rland, Aug. 7 /- ESBATech AG, a leadi...day announced that the,company has raised an addit...ries B venture round to expand its development pip...ticipated in this round including SV Life,Sciences...
(Date:8/6/2008)...manently implanted into the heart works,with an el...s patient,s,pulmonary artery pressure, CHICAGO, A...ortness of,breath are common symptoms that send te...o U.S. hospitals each month. Cardiologists at the ...orial Hospital may be able to,curb such visits for...
(Date:8/6/2008)...re-FirstCall/ -- GlaxoSmithKline (NYSE:,GSK) (GSK)...4,600 patients,in 54 clinical studies showed no in...ith the anti-HIV medication abacavir. GSK conducte...rtaken by the D:A:D cohort had found an,unexpected...ntiretroviral,therapy (HAART) regimens containing ...
(Date:8/6/2008)...s $15 million payment from collaborator ...., Aug. 6 /- Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...l Phase 3 clinical trial that is evaluating otelix... a result of the initiation of,patient dosing in D...
Breaking Medicine Technology:ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing 2ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing 3New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorial's Bluhm Cardiovascular Institute 2New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorial's Bluhm Cardiovascular Institute 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 2Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 4Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 5Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 2Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 3Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 4Cipher appoints Stefan Aigner to board of directors 7671 1Cipher appoints Stefan Aigner to board of directors 7671 2Cipher appoints Stefan Aigner to board of directors 7671 3Wyeth Receives Honors at the 2007 Scrip Awards 7667 1Wyeth Receives Honors at the 2007 Scrip Awards 7667 2Wyeth Receives Honors at the 2007 Scrip Awards 7667 3Wyeth Receives Honors at the 2007 Scrip Awards 7667 4Wyeth Receives Honors at the 2007 Scrip Awards 7667 5Dads break bones of children more often than moms 7663 1Dads break bones of children more often than moms 7663 2Scientists identify gene that influences alcohol consumption 7659 1Scientists identify gene that influences alcohol consumption 7659 2
...al protection,against infection with other cancer-...PRNewswire-FirstCall/ -- The,GlaxoSmithKline cervi...rated 100 percent efficacy in preventing precancer...irus types 16 and 18,for up to 5.5 years in an ext... today at the American Association for Cancer,Rese...
...st-Ever IVF Trial,in US, RANCHO MIRAGE, Calif., Ap...es evaluating Ferring Pharmaceuticals, ENDOMETRIN(...ment for luteal phase,support (supplementation to ...ges of pregnancy) in assisted reproductive,technol...ing of the,Pacific Coast Reproductive Society in R...
Other Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5